Recombinant Bacillus cereus UPF0316 protein BCG9842_B1857 (BCG9842_B1857)

How does BCG9842_B1857 relate to homologous proteins in other Bacillus species?

BCG9842_B1857 shares significant sequence homology with UPF0316 proteins from other Bacillus species, most notably:

This high conservation is particularly significant between B. cereus and B. anthracis, which are closely related evolutionarily . The gene cluster containing BCG9842_B1857 in B. cereus is highly conserved with the ba1554-ba1558 cluster in B. anthracis and the bt1364-bt1368 cluster in B. thuringiensis, indicating critical roles for these proteins in the Bacillus genus .

The study of BCG9842_B1857 from B. cereus can serve as a useful model for understanding the function of its homologs in more pathogenic species like B. anthracis, which requires higher biosafety level facilities for research .

What are the optimal expression systems for recombinant BCG9842_B1857 production?

E. coli is the most commonly used expression system for recombinant production of BCG9842_B1857. Based on established protocols for similar Bacillus proteins, the following expression strategy is recommended :

• Gene amplification: PCR amplification of the BCG9842_B1857 gene from B. cereus genomic DNA using specific primers with appropriate restriction sites (e.g., BamHI and SalI)

• Vector construction: Cloning into a modified pET49b vector (pET49bm) or similar expression vectors that provide N-terminal affinity tags

• Host strain selection: For membrane proteins like BCG9842_B1857, specialized E. coli strains designed for membrane protein expression (e.g., C41(DE3) or C43(DE3)) typically yield better results than standard strains

• Expression optimization:

Lower induction temperatures (18°C) generally improve the solubility of membrane proteins like BCG9842_B1857 by slowing protein synthesis and allowing proper folding .

What purification strategies yield the highest purity and stability for BCG9842_B1857?

Purifying transmembrane proteins like BCG9842_B1857 requires specialized approaches. The following multi-step purification strategy is recommended:

• Cell lysis and membrane protein extraction:

  • Mechanical disruption (sonication or French press)

  • Membrane fraction isolation by ultracentrifugation

  • Solubilization with appropriate detergents (e.g., n-dodecyl-β-D-maltoside (DDM) or lauryl maltose neopentyl glycol (LMNG))

• Affinity chromatography:

  • Nickel-NTA for His-tagged proteins

  • Buffer: 50 mM Tris pH 8.0, 150 mM NaCl, 0.1% detergent, 20-250 mM imidazole gradient

  • Expected purity: 80-85%

• Size-exclusion chromatography (SEC):

  • Critical for removing aggregates and determining oligomeric state

  • Buffer: 50 mM Tris pH 8.0, 150 mM NaCl, 0.05% detergent

  • Expected final purity: >90-95%

• Storage considerations:

  • 50% glycerol significantly improves stability during storage

  • Store at -20°C/-80°C with aliquoting to avoid freeze-thaw cycles

  • Working aliquots can be stored at 4°C for up to one week

The addition of stabilizing agents such as glycerol and trehalose (6%) in storage buffers has been shown to significantly enhance the stability of UPF proteins from Bacillus species .

What biophysical techniques are most effective for characterizing BCG9842_B1857?

Several biophysical techniques provide valuable insights into the structure and function of BCG9842_B1857:

• Crystallography and structural determination:

  • X-ray crystallography for high-resolution 3D structure

  • Crystallization conditions need extensive optimization for membrane proteins

  • Crystal sizes >0.1 mm are typically required for diffraction

• Secondary structure and stability analysis:

  • Circular dichroism (CD) spectroscopy to assess secondary structure content

  • Thermal shift assays to determine protein stability and optimal buffer conditions

  • Size-exclusion chromatography coupled with multi-angle light scattering (SEC-MALS) for oligomerization state determination

• Membrane topology studies:

  • Cysteine accessibility methods

  • Fluorescence-based approaches

  • Limited proteolysis coupled with mass spectrometry

  • Computational predictions validated experimentally

• Functional assays:

  • Liposome reconstitution for transport studies

  • Electrophysiology for channel activity assessment

  • Binding assays for potential ligands/substrates

These methods should be used in combination to build a comprehensive understanding of BCG9842_B1857's structure-function relationship, as has been done for other UPF proteins from Bacillus species .

How can site-directed mutagenesis help elucidate functional domains of BCG9842_B1857?

Site-directed mutagenesis is a powerful approach to identify critical residues and functional domains in BCG9842_B1857:

• Target selection strategies:

  • Conserved residues identified through multiple sequence alignment across Bacillus species

  • Predicted transmembrane domains based on hydrophobicity analysis

  • Charged residues in potential binding pockets or channel-forming regions

  • Residues conserved in UPF0316 family but not in other protein families

• Recommended mutation approaches:

  • Alanine scanning of conserved residues

  • Conservative and non-conservative substitutions

  • Domain swapping with homologs

  • Introduction of reporter tags at different positions to study topology

• Functional assessment methods:

  • Expression level comparison (Western blot)

  • Membrane localization (fractionation studies)

  • Stability comparison (thermal shift assays)

  • Activity assays once the function is better defined

This systematic approach has been successfully applied to other membrane proteins from Bacillus species to elucidate structure-function relationships .

How does BCG9842_B1857 potentially contribute to B. cereus pathogenicity and virulence?

While the direct role of BCG9842_B1857 in pathogenicity remains unclear, several hypotheses can be investigated:

• Potential virulence-related functions:

  • Membrane integrity maintenance during host infection

  • Environmental sensing of host conditions

  • Stress response enabling survival in hostile environments

  • Nutrient acquisition or transport during infection

  • Biofilm formation contribution

• Research approaches to test these hypotheses:

  • Gene knockout studies and virulence assessment in infection models

  • Transcriptomics to identify co-regulated genes during infection

  • Comparative genomics across strains with different virulence profiles

  • Protein-protein interaction studies to identify partners in virulence pathways

• Relevance to B. cereus as a foodborne pathogen:

  • B. cereus causes food intoxications worldwide

  • Understanding conserved proteins may reveal new pathogenic mechanisms

  • BCG9842_B1857 could be involved in survival in food matrices

Genome-wide studies of B. cereus virulence factors have identified numerous proteins associated with pathogenicity, and systematic functional characterization of conserved proteins like BCG9842_B1857 will help complete our understanding of B. cereus pathogenesis .

What are the latest methodologies for studying protein-protein interactions of BCG9842_B1857?

Understanding protein-protein interactions is crucial for elucidating BCG9842_B1857's function:

• In vitro interaction detection methods:

  • Pull-down assays using affinity-tagged BCG9842_B1857

  • Surface plasmon resonance (SPR) for interaction kinetics

  • Isothermal titration calorimetry (ITC) for thermodynamic parameters

  • Crosslinking coupled with mass spectrometry for interaction mapping

• In vivo interaction detection approaches:

  • Bacterial two-hybrid systems

  • Co-immunoprecipitation from B. cereus lysates

  • Proximity labeling techniques (BioID, APEX)

  • Fluorescence resonance energy transfer (FRET)

• Validation and functional assessment:

  • Reciprocal pull-downs with identified partners

  • Mutagenesis of binding interfaces

  • Co-expression studies

  • Phenotypic analysis of interaction-deficient mutants

• Bioinformatic prediction:

  • Use of machine learning algorithms to predict potential interaction partners

  • Structural modeling of protein complexes

  • Evolutionary analysis of co-evolving residues

These approaches provide complementary information that can help build a comprehensive interactome for BCG9842_B1857.

How do UPF0316 proteins vary across different Bacillus species, and what does this tell us about their evolution?

Comparative analysis of UPF0316 proteins across Bacillus species provides valuable evolutionary insights:

• Sequence conservation patterns:

  • The core transmembrane domains show highest conservation

  • N- and C-terminal regions display more variability

  • Key charged residues are typically conserved across species

  • Sequence identity between B. cereus BCG9842_B1857 and B. anthracis BAA_3454 is approximately 90%

• Evolutionary implications:

  • High conservation suggests essential cellular functions

  • Conservation across pathogenic and non-pathogenic species indicates roles beyond virulence

  • Gene cluster conservation (BCG9842_B1857 in B. cereus, ba1554 in B. anthracis, BALH_3038 in B. thuringiensis) suggests functional linkage with neighboring genes

• Research applications:

  • Using less pathogenic B. cereus as model for studying B. anthracis proteins

  • Identifying species-specific variations that might reflect niche adaptation

  • Understanding evolutionary pressure on membrane proteins in Bacillus species

The significant homology between these proteins makes B. cereus BCG9842_B1857 an excellent model for studying the more pathogenic B. anthracis homolog without the biosafety level 3 (BSL-3) requirements .

How can structural insights from related UPF proteins inform our understanding of BCG9842_B1857?

Structural information from related UPF proteins can provide valuable insights into BCG9842_B1857:

• Cross-family structural comparisons:

  • UPF0042 and UPF0234 proteins from Bacillus species have been better characterized

  • Common structural motifs may suggest functional similarities

  • Differences in structural elements may indicate specialized functions

• Structure prediction approaches:

  • AlphaFold or similar AI-based prediction tools

  • Threading methods using solved structures of related proteins

  • Molecular dynamics simulations to predict behavior in membranes

  • Validation of predicted structures through limited experimental data

• Structure-guided functional hypotheses:

  • Channel or pore-forming capabilities based on hydrophobic patterns

  • Ligand binding pockets identification

  • Oligomerization interfaces prediction

  • Post-translational modification sites identification

• Experimental validation strategies:

  • Targeted mutagenesis of predicted functional sites

  • Chimeric protein construction

  • Domain-specific antibodies or nanobodies development

  • Limited proteolysis patterns compared to predictions

By combining structural insights from related proteins with targeted experimental validation, researchers can accelerate our understanding of BCG9842_B1857 function.

How can CRISPR-Cas9 genome editing facilitate functional studies of BCG9842_B1857?

CRISPR-Cas9 technology offers powerful approaches for studying BCG9842_B1857 function:

• Gene knockout strategies:

  • Complete deletion to assess essentiality

  • Conditional knockouts if the gene is essential

  • Scarless genomic modifications

  • Multiplexed editing to target redundant genes simultaneously

• Precise genomic modifications:

  • Introduction of point mutations to test specific hypotheses

  • Insertion of reporter tags for localization studies

  • Promoter replacements to control expression levels

  • Introduction of regulated degradation systems

• High-throughput functional genomics:

  • CRISPR interference (CRISPRi) for tunable repression

  • CRISPR activation (CRISPRa) for overexpression

  • Saturating mutagenesis across the gene

  • Genetic interaction mapping through double knockouts

• Implementation considerations for Bacillus cereus:

  • Optimized Cas9 expression for Gram-positive bacteria

  • Efficient delivery methods (electroporation or conjugation)

  • Appropriate selection markers

  • Temperature-sensitive plasmids for transient expression

CRISPR-based approaches allow unprecedented precision in genetic manipulation, enabling detailed functional characterization of BCG9842_B1857 in its native context.

What are the latest mass spectrometry approaches for characterizing membrane proteins like BCG9842_B1857?

Advanced mass spectrometry techniques offer powerful tools for membrane protein characterization:

• Native mass spectrometry:

  • Analysis of intact membrane protein complexes

  • Determination of oligomeric states

  • Characterization of non-covalent interactions

  • Detection of bound lipids or ligands

• Hydrogen-deuterium exchange mass spectrometry (HDX-MS):

  • Probing solvent accessibility and dynamics

  • Identifying conformational changes upon ligand binding

  • Mapping interaction interfaces

  • Detecting structural flexibility

• Cross-linking mass spectrometry (XL-MS):

  • Capturing spatial relationships between residues

  • Validating structural models

  • Identifying interaction partners

  • Elucidating complex topologies

• Targeted proteomics:

  • Precise quantification using selected reaction monitoring (SRM)

  • Absolute quantification with synthetic peptide standards

  • Analysis of post-translational modifications

  • Detection of low-abundance proteoforms

• Sample preparation considerations:

  • Specialized detergents compatible with MS

  • Nanodiscs or amphipols as alternatives to detergents

  • Optimized digestion protocols for hydrophobic peptides

  • Enrichment strategies for post-translational modifications

These advanced MS approaches provide complementary structural and functional information that can significantly accelerate our understanding of challenging membrane proteins like BCG9842_B1857.

What are common challenges in BCG9842_B1857 expression and how can they be overcome?

Researchers frequently encounter several challenges when working with BCG9842_B1857:

• Low expression levels:

  • Solution: Optimize codon usage for E. coli, test different promoters, and use specialized strains like C41(DE3) designed for membrane proteins

  • Method: Compare expression across multiple constructs with different fusion tags (His, GST, MBP) and evaluate expression using Western blotting

• Protein aggregation:

  • Solution: Lower induction temperature (16-18°C), reduce IPTG concentration, and add solubilizing agents like arginine

  • Method: Monitor soluble vs. insoluble fractions during expression optimization

• Proteolytic degradation:

  • Solution: Add protease inhibitors during purification, use protease-deficient expression strains, and optimize buffer composition

  • Method: Analyze stability through time-course experiments with SDS-PAGE

• Poor membrane extraction:

  • Solution: Screen multiple detergents (DDM, LMNG, CHAPS) at various concentrations

  • Method: Systematically test extraction efficiency through quantitative Western blot analysis of solubilized vs. remaining membrane fractions

• Low purification yield:

  • Solution: Optimize each purification step independently, minimize sample handling, and maintain cold temperatures throughout

  • Method: Track protein quantity and quality at each step using protein assays and SDS-PAGE

Success in expression and purification often requires iterative optimization of multiple parameters simultaneously.

How can researchers troubleshoot crystallization problems with BCG9842_B1857?

Crystallization of membrane proteins like BCG9842_B1857 is challenging but can be approached systematically:

• Initial screening strategies:

  • Use specialized membrane protein crystallization screens

  • Try both vapor diffusion and lipidic cubic phase methods

  • Screen multiple detergents and detergent concentrations

  • Test various protein concentrations (5-15 mg/mL)

• Construct optimization:

  • Remove flexible termini based on limited proteolysis

  • Create fusion proteins with crystallization chaperones (T4 lysozyme, BRIL)

  • Generate antibody fragments or nanobodies to stabilize specific conformations

  • Try homologs from thermophilic organisms

• Crystal optimization approaches:

  • Fine-tune precipitant concentration and pH

  • Implement microseeding techniques

  • Add specific lipids or ligands

  • Adjust crystallization temperature

• Dealing with common issues:

  • Problem: Phase separation
    Solution: Adjust detergent concentration or try different detergent types

  • Problem: Microcrystals
    Solution: Implement seeding, slow down crystal growth with lower temperatures

  • Problem: Poor diffraction
    Solution: Post-crystallization treatments, dehydration, or crystal annealing

• Alternative approaches:

  • Cryo-electron microscopy for structure determination without crystals

  • Nuclear magnetic resonance for structural elements in solution

  • Small-angle X-ray scattering for low-resolution envelope structures

Successful crystallization typically requires testing hundreds of conditions and multiple protein constructs.

What strategies can improve the solubility and stability of recombinant BCG9842_B1857?

Improving solubility and stability of BCG9842_B1857 requires multi-faceted approaches:

• Buffer optimization:

  • Systematic screening of pH (range 6.0-9.0)

  • Testing various salt types (NaCl, KCl) and concentrations (100-500 mM)

  • Addition of stabilizing agents (glycerol 5-20%, trehalose 5-10%)

  • Incorporation of specific lipids or lipid-like molecules

• Fusion partners and tags:

  • Solubility-enhancing fusion partners (MBP, SUMO)

  • Stabilizing tags that can be removed post-purification

  • Optimization of linker length between the protein and fusion partner

  • Testing tag position (N-terminal vs. C-terminal)

• Protein engineering approaches:

  • Surface entropy reduction through mutation of flexible loops

  • Substitution of exposed hydrophobic residues

  • Introduction of disulfide bridges for stability

  • Removal of proteolytically sensitive regions

• Storage and handling considerations:

  • Optimal glycerol concentration (typically 50%)

  • Flash freezing in liquid nitrogen vs. slow freezing

  • Addition of reducing agents for proteins with cysteines

  • Aliquoting to avoid freeze-thaw cycles

• Empirical stability testing:

  • Thermal shift assays to assess stability in different conditions

  • Size-exclusion chromatography to monitor aggregation over time

  • Activity assays to correlate stability with function

  • Light scattering techniques to detect early aggregation events